Could a common stroke drug speed up brain bleed recovery?
NCT ID NCT06504576
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether cilostazol, a drug already used for stroke prevention, can help the body clear blood clots from the brain after a hemorrhagic stroke. About 100 adults with a moderate brain bleed will receive either cilostazol plus standard care or standard care alone for two weeks. Researchers will use MRI scans to measure clot shrinkage and track recovery over three months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ICH - INTRACEREBRAL HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Taiwan University Hospital
RECRUITINGTaipei, Not Required For This Country, 100225, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ambulance vital signs may hold clues to brain bleeding outcomes
- Brain bleed survivors studied for clot Removal's Long-Term brain benefits
- Could a cheap arthritis drug cut stroke survivors' heart risks?
- New hope for heart patients with brain bleed history: catheter ablation vs. standard care
- New combo therapy aims to boost recovery after stroke